Showing 41-50 of 3104 results for "".
- MDA Provides COVID-19 Recommendations for People with Neuromuscular Conditions that Also Apply to Other Neurologic Conditionshttps://practicalneurology.com/news/mda-provides-covid-19-recommendations-for-people-with-neuromuscular-conditions-that-also-apply-to-other-neurologic-conditions/2469188/The Muscular Dystrophy Association (MDA) has provided recommendations for people in the neuromuscular community regarding the current COVID-19 pandemic. Noting that current guidelines from public health agencies focus on travelers, specific age group
- Study Evaluates Botox as Essential Tremor Treatmenthttps://practicalneurology.com/news/study-evaluates-botox-as-essential-tremor-treatment/2483937/Treatment with Botox (onabotulinumtoxinA; AbbVie, North Chicago, IL) was associated with significant improvements in functional outcomes in people with upper limb essential tremor (ET) compared with placebo in study results presented at the 2025 International Congress of Parkinson’s Disease and M
- Accelerated FDA Approval Granted to First Treatment Targeting H3 K27M-Mutant Diffuse Midline Gliomahttps://practicalneurology.com/news/fda-grants-accelerated-approval-to-first-treatment-targeting-h3-k27m-mutant-diffuse-midline-glioma/2476100/The Food and Drug Administration (FDA) granted accelerated approval to Modeyso (dordaviprone; Jazz Pharmaceuticals, Dublin, Ireland) for the treatment of adults and children aged ≥1 year with diffuse midline glioma harboring the H3 K27M mutation with disease progression following prior therapy. M
- Commercial Launch of Sensing Technology for Closed-Loop Spinal Cord Stimulation System Announcedhttps://practicalneurology.com/news/commercial-launch-of-sensing-technology-for-closed-loop-spinal-cord-stimulation-system-announced/2475782/Saluda Medical (Minneapolis, MN) has announced the full commercial launch of EVA Sensing Technology to support the treatment of people with chronic pain conditions. The device is designed to be used with the company’s closed-loop spinal cord stimulation system—the Evoke SmartLoop System (Saluda M
- New Recommendations on Glucocorticoid Treatment for People with Neuromuscular Disordershttps://practicalneurology.com/news/new-guidelines-published-for-glucocorticoid-treatment-for-people-with-neuromuscular-disorders/2474507/A multidisciplinary expert panel has released new consensus-based recommendations on glucocorticoid use for people with neuromuscular disorders, aiming to streamline clinical decisions amid a lack of specific, formal guidelines. Published in Muscle and Nerve, the guidance aims to support safer, m
- Wrist-Worn Neurostimulation Device for Hand Movement Rehabilitation after Stroke or Spinal Injury Receives FDA Clearancehttps://practicalneurology.com/news/wrist-worn-neurostimulation-device-for-hand-movement-rehabilitation-after-stroke-or-spinal-injury-receives-fda-clearance/2473788/The Food and Drug Administration (FDA) has granted 510(K) clearance to NeuStim (Neuvotion, Stamford, CT), a noninvasive, surgery-free wearable neurostimulation device used to aid in hand movement recovery in patients who have experienced a stroke or spinal cord injury (SCI). The device can scan m
- Eight Potential Alternative/Off-Label Treatments for ALS Identified by Researchershttps://practicalneurology.com/news/eight-potential-alternativeoff-label-treatments-for-als-identified-by-researchers/2473774/Researchers have identified 8 alternative and off-label treatments (AOTs) which may have efficacy for targeting some of the multiple, overlapping pathogenic mechanisms thought to underly amyotrophic lateral sclerosis (ALS), such as neuroinflammation, oxidative stress, mitochondrial dysfunction, m
- NFL Players Wear Cleats to Support Muscular Dystrophy Associationhttps://practicalneurology.com/news/the-muscular-dystrophy-society-represented-in-the-nfls-my-cause-my-cleats-campaign/2470660/During the “My Cause My Cleats” campaign, which took place during the first 2 weeks of December, several National Football League (NFL) players wore custom-designed cleats to support causes important to them. Nyheim Hines, 2024 Muscular Dystrophy Association (M
- Frailty Linked to Greater Risk of Dementiahttps://practicalneurology.com/news/frailty-linked-to-greater-risk-of-dementia/2470643/Frailty measurements may enable the identification of individuals at higher risk of dementia up to 9 years before the onset of the disorder, according to study results published in JAMA Neurology. According to the study authors, the findings demonstrate the potential utility of frailty m
- American Epilepsy Society Establishes Travel Award for Studentshttps://practicalneurology.com/news/aes-establishes-travel-grant-for-students/2470638/The American Epilepsy Society (AES) has established the Eileen M. Murray, MM, CAE, First-Generation Travel Award, consisting of a $1000 travel stipend and complimentary registration to the AES Annual Meeting. The award is intended to support first-generation medical, graduate, nursing, pharmacy,